Fortis board gives nod for diagnostic arm IPO, net profit drops 9% in Q1FY24
Fortis Healthcare board on Friday approved its diagnostic arm Agilus to initiate an initial public offer process, by way of an offer of sale by the latter’s existing and eligible shareholders in the IPO. Agilus was earlier called SRL Diagnostics, which was rebranded in May this year. “The actual timing and implementation of the IPO … Read more